Skip to main content
. 2021 Oct 31;26(21):6596. doi: 10.3390/molecules26216596

Figure 1.

Figure 1

2D structure of the FDA-approved proteasome inhibitors BTZ (A), CFZ (B) and Ixazomib (C).